Fat-loaded HepG2 spheroids exhibit enhanced protection from pro-oxidant and cytokine induced damage

Journal of Cellular Biochemistry

Volumn 101, Issue 3, 2007, Pages 723-734

  Damelin, Leonard H ^a   Coward, Sam ^a   Kirwan, Michael ^a   Collins, Peter ^a   Selden, Clare ^a   Hodgson, Humphrey J F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AMPK; HepG2; NAFLD; NASH; Oxidative stress; Spheroids

Indexed keywords

CYTOKINE; FAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OLEIC ACID; OXIDIZING AGENT; PALMITIC ACID; SUPEROXIDE DISMUTASE; TERT BUTYL HYDROPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; ARTICLE; BODY FAT; CELL PROTECTION; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; SPHEROID CELL; STATISTICAL SIGNIFICANCE; STEATOSIS;

CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPID METABOLISM; MICROSCOPY, ELECTRON, TRANSMISSION; MULTIENZYME COMPLEXES; OLEIC ACID; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; SPHEROIDS, CELLULAR; SUPEROXIDE DISMUTASE; TERT-BUTYLHYDROPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247881876     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21229     Document Type: Article

References (27)

1. Damelin LH, Coward S, Choudhury SF, Chalmers S, Cox IJ, Robertson NJ, Revial G, Miles M, Tootle R, Hodgson HJ, Selden C. 2004. Altered mitochondrial function and cholesterol synthesis influences protein synthesis in extended HepG2 spheroid cultures. Arch Biochem Biophys 434:167-177.
2. Day CP. 2002. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 16:663-678.
3. Day CP, James OF. 1998. Steatohepatitis: A tale of two "hits"? Gastroenterology 114:842-845.
4. Diaz-Guerra MJ, Junco M, Bosca L. 1991. Oleic acid promotes changes in the subcellular distribution of protein kinase C in isolated hepatocytes. 266:23568-23576.
5. Farrell GC, Larter CZ. 2006. Non-alcoholic fatty liver: From steatosis to cirrhosis. Hepatology 43:S99-S112.
6. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ. 2004. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40:185-194.
7. Greenspan P, Mayer EP, Fowler SD. 1985. Nile red: A selective fluorescent stain for intracellular lipid droplets. J Cell Biol 100:965-973.
8. Jones LJ, Singer VL. 2001. Fluorescence microplate-based assay for tumor necrosis factor activity using SYTOX Green stain. Anal Biochem 293:8-15.
9. Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K. 2002. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: Regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem 277:3829-3835.
10. Khalil M, Shariat-Panahi A, Tootle R, Ryder T, McCloskey P, Roberts E, Hodgson H, Selden C. 2001. Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly up-regulate both synthetic and detoxificatory liver function. J Hepatol 34:68-77.
11. Lenaerts I, Braeckman BP, Matthijssens F, Vanfleteren JR. 2002. A high-throughput microtiter plate assay for superoxide dismutase based on lucigenin chemiluminescence. Anal Biochem 311:90-92.
12. Lieber CS. 2004. CYP2E1: From ASH to NASH. Hepatol Res 28:1-11.
13. Machado M, Cortez-Pinto H. 2005. Non-alcoholic fatty liver disease and insulin resistance. Eur J Gastroenterol Hepatol 17:823-826.
14. Mackay K, Mochly-Rosen D. 2001. Arachidonic acid projects neonatal rat cardiac myocytes from ischaemic injury through epsilon protein kinase C. Cardiovasc Res 50:65-74.
15. McCullough AJ. 2006. Pathophysiology of non-alcoholic steatohepatitis. J Clin Gastroenterol 40:S17-29.
16. Mu J, Brozinick JT Jr, Valladares O, Bucan M, Birnbaum MJ. 2001. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7:1085-1094.
17. Nobili V, Pastore A, Gaeta LM, Tozzi G, Comparcola D, Sartorelli MR, Marcellini M, Bertini E, Piemonte F. 2005. Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin Chim Acta 355:105-111.
18. Rodriguez-Antona C, Donato MT, Boobis A, Edwards RJ, Watts PS, Castell JV, Gomez-Lechon MJ. 2002. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: Molecular mechanisms that determine lower expression in cultured cells. Xenobiotica 32: 505-520.
19. Rutter GA, Da SX, Leclerc I. 2003. Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 375(Pt 1):1-16.
20. Salt IP, Johnson G, Ashcroft SJ, Hardie DG. 1998. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J 335(Pt 3):533-539.
21. Sanyal AJ. 2005. Mechanisms of Disease: Pathogenesis of non-alcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2:46-53.
22. Scharnagl H, Schinker R, Gierens H, Nauck M, Wieland H, Marz W. 2001. Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol arid triacylglycerides in HepG2 cells. Biochem Pharmacol 62:1545-1555.
23. Sebastia J, Cristofol R, Martin M, Rodrigues-Farre E, Sanfeliu C. 2003. Evaluation of fluorescent dyes for measuring intracellular glutathione content in primary cultures of human neurons and neuroblastoma SH-SY5Y. Cytometry 51A(Pt A):16-25.
24. Shimabukuro M, Zhou YT, Lee Y, Unger RH. 1998. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 273: 3547-3550.
25. Sung M, Kim I, Park M, Whang Y, Lee M. 2004. Differential effects of dietary fatty acids on the regulation of CYP2E1 and protein kinase C in human hepatoma HepG2 cells. J Med Food 7:197-203.
26. Taylor EB, Ellingson WJ, Lamb JD, Chesser DG, Winder WW. 2005. Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine 172 by LKB1/STRAD/MO25 Am J Physiol Endocrinol Metab 288:E1055-61.
27. Wu M, Lin Z, Wolfbeis OS. 2003. Determination of the activity of catalase using a Europium(III)-tetracycline-derived fluorescent substrate. Anal Biochem 320:129-135.